Profil
Anna Gralinska is currently the Head of Corporate Communications at Bio-Rad Laboratories, Inc. She previously worked as the Director of Investor Relations at Mallinckrodt Hospital Products, Inc.
Postes actifs de Anna Gralinska
| Sociétés | Poste | Début |
|---|---|---|
| BIO-RAD LABORATORIES, INC. | Public Communications Contact | 01/04/2022 |
Anciens postes connus de Anna Gralinska
| Sociétés | Poste | Fin |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIO-RAD LABORATORIES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |